This inventor holds 2 USPTO granted patents. Top assignees: Mogam Institute for Biomedical Research, The Green Cross Corporation. Active years: 2022-2026.
Company Filing History:
2 out of 17 
2 out of 264 
Years Active: 2022-2026
Title: Aerin Yoon: Innovator in Cancer Treatment
Introduction
Aerin Yoon is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of anti-cancer agents. His innovative work focuses on enhancing immune responses against cancer cells.
Latest Patents
Aerin Yoon holds a patent for an "Anti-CEACAM1 antibody and use thereof." This invention provides anti-CEACAM1 antibodies with improved binding abilities specific to CEACAM1. The antibodies exhibit superior binding capabilities and activate the anti-cancer immune functions of cytotoxic T cells and natural killer cells. Consequently, these antibodies can be effectively utilized as anti-cancer agents and compositions for treating cancer.
Career Highlights
Throughout his career, Aerin Yoon has worked with esteemed organizations such as the Mogam Institute for Biomedical Research and the Green Cross Corporation. His experience in these institutions has allowed him to advance his research and contribute to significant developments in cancer treatment.
Collaborations
Aerin has collaborated with talented individuals in his field, including So-Young Eun and Miyoung Oh. Their combined efforts have furthered research initiatives and innovations in cancer therapies.
Conclusion
Aerin Yoon's work in developing anti-CEACAM1 antibodies represents a promising advancement in cancer treatment. His contributions to biomedical research highlight the importance of innovation in the fight against cancer.